Repligen Price to Sales Ratio vs Operating Margin Analysis
RGEN Stock | USD 171.28 13.80 8.76% |
Repligen financial indicator trend analysis is much more than just breaking down Repligen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Repligen is a good investment. Please check the relationship between Repligen Price To Sales Ratio and its Operating Profit Margin accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
Price To Sales Ratio vs Operating Profit Margin
Price to Sales Ratio vs Operating Margin Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Repligen Price to Sales Ratio account and Operating Margin. At this time, the significance of the direction appears to have no relationship.
The correlation between Repligen's Price to Sales Ratio and Operating Margin is 0.0. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Operating Margin in the same time period over historical financial statements of Repligen, assuming nothing else is changed. The correlation between historical values of Repligen's Price to Sales Ratio and Operating Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of Repligen are associated (or correlated) with its Operating Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Margin has no effect on the direction of Price to Sales Ratio i.e., Repligen's Price to Sales Ratio and Operating Margin go up and down completely randomly.
Correlation Coefficient | 0.0 |
Relationship Direction | Flat |
Relationship Strength | Insignificant |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Repligen stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Repligen sales, a figure that is much harder to manipulate than other Repligen multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Operating Profit Margin
Most indicators from Repligen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's Selling General Administrative is very stable compared to the past year. As of the 23rd of April 2024, Enterprise Value Over EBITDA is likely to grow to 79.75, while Tax Provision is likely to drop about 7.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 391.3M | 455.7M | 284.2M | 538.9M | Total Revenue | 670.5M | 801.5M | 638.8M | 768.0M |
Repligen fundamental ratios Correlations
Click cells to compare fundamentals
Repligen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Repligen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.4B | 1.9B | 2.4B | 2.5B | 2.8B | 3.0B | |
Short Long Term Debt Total | 263.3M | 275.4M | 366.1M | 423.0M | 711.8M | 747.4M | |
Other Current Liab | 28.3M | 37.8M | 60.7M | 65.8M | 53.2M | 55.9M | |
Total Current Liabilities | 48.3M | 319.0M | 375.3M | 404.2M | 158.2M | 166.1M | |
Total Stockholder Equity | 5.8M | 65.8M | 1.8B | 397.3M | 2.0B | 2.1B | |
Property Plant And Equipment Net | 74.2M | 92.0M | 226.5M | 315.7M | 323.0M | 339.1M | |
Net Debt | (265.1M) | (441.9M) | (237.8M) | (100.5M) | (39.5M) | (41.5M) | |
Retained Earnings | 5.8M | 65.8M | 194.1M | 397.3M | 438.8M | 460.8M | |
Cash | 528.4M | 717.3M | 603.8M | 523.5M | 751.3M | 788.9M | |
Non Current Assets Total | 758.3M | 1.0B | 1.4B | 1.5B | 1.7B | 1.8B | |
Non Currrent Assets Other | 238K | 573K | 615K | 815K | 1.3M | 1.3M | |
Cash And Short Term Investments | 528.4M | 717.3M | 603.8M | 623.8M | 751.3M | 788.9M | |
Net Receivables | 43.7M | 71.4M | 117.4M | 116.2M | 124.2M | 130.4M | |
Common Stock Shares Outstanding | 49.2M | 53.9M | 57.3M | 57.5M | 56.4M | 29.9M | |
Liabilities And Stockholders Equity | 346.2M | 439.5M | 2.4B | 1.0B | 2.8B | 3.0B | |
Non Current Liabilities Total | 292.0M | 54.8M | 233.0M | 209.8M | 695.0M | 729.8M | |
Inventory | 54.8M | 95.0M | 184.5M | 238.3M | 202.3M | 212.4M | |
Other Current Assets | 3.1M | 14.1M | 19.3M | 17.4M | 33.2M | 34.9M | |
Other Stockholder Equity | 14.5M | (2.6M) | 1.6B | 33.8M | 1.6B | 1.6B | |
Total Liab | 340.3M | 373.7M | 608.3M | 614.0M | 853.2M | 895.9M | |
Property Plant And Equipment Gross | 74.2M | 92.0M | 297.2M | 408.0M | 451.7M | 474.3M | |
Total Current Assets | 641.8M | 902.4M | 931.7M | 998.1M | 1.1B | 1.2B | |
Accumulated Other Comprehensive Income | (15.0M) | 2.1M | (16.9M) | (34.4M) | (37.4M) | (35.6M) | |
Accounts Payable | 11.4M | 16.9M | 36.2M | 27.6M | 19.6M | 20.5M | |
Short Term Debt | 3.6M | 249.0M | 263.6M | 291.6M | 75.1M | 101.1M | |
Other Assets | 3.2M | 28.2M | 2.5M | 1.7M | 1.5M | 1.6M | |
Common Stock Total Equity | 521K | 548K | 553K | 556K | 639.4K | 389.2K | |
Common Stock | 521K | 548K | 553K | 556K | 558K | 398.5K | |
Property Plant Equipment | 48.5M | 66.9M | 125.0M | 190.7M | 219.3M | 230.2M | |
Other Liab | 32.3M | 28.4M | 130.5M | 78.4M | 90.1M | 94.6M | |
Current Deferred Revenue | 5.0M | 15.3M | 14.8M | 19.3M | 10.3M | 5.4M | |
Good Will | 468.4M | 618.3M | 860.4M | 855.5M | 987.1M | 1.0B | |
Intangible Assets | 212.6M | 287.1M | 337.3M | 353.7M | 400.5M | 420.5M | |
Net Tangible Assets | 378.8M | 623.7M | 552.4M | 701.5M | 806.7M | 847.1M | |
Retained Earnings Total Equity | 5.8M | 65.8M | 194.1M | 397.3M | 456.9M | 479.7M | |
Capital Surpluse | 1.1B | 1.5B | 1.6B | 1.5B | 1.8B | 1.9B |
Currently Active Assets on Macroaxis
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 0.74 | Revenue Per Share 11.464 | Quarterly Revenue Growth (0.17) | Return On Assets 0.0131 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.